Verve Therapeutics
Developing gene editing therapies
- B2B
About Verve Therapeutics
A clinical-stage biotech company focused on developing gene editing therapies to permanently lower LDL cholesterol levels and protect against heart disease
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- boston, massachusetts, United States
- Founded
- 2018
- Revenue
- $32.3MFY2024, publicly reported
- Website
- vervetx.com
Verve Therapeutics at a glance
Verve Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in boston, massachusetts, United States.
Verve Therapeutics was founded in 2018.
Verve Therapeutics has 51–250 employees.
Verve Therapeutics's revenue is $32.3M (FY2024, publicly reported).
Selling to companies like Verve Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies